# IQVIA

指定患者与患者支持计划最大的商业化合作伙伴，依托超过5,000次支持上市的记录与LAAD数据集；2026年5月13日扩展了与科兴生物制药（688136.SH）基于AI的生物类似药合作，覆盖临床、监管与商业化服务。

Source: https://cn.bioecon.ru/companies/iqvia/
Updated: 2026-08-15

- 国家: United States
- 代码: NYSE: IQV

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 总部 | 美国北卡罗来纳州Durham | https://umbrex.com/resources/company-profiles/iqvia/ |
| 员工人数 | 约93,000名员工 | https://ir.iqvia.com/press-releases/press-release-details/2026/IQVIA-Reports-Fourth-Quarter-and-Full-Year-2025-Results-Issues-Full-Year-2026-Guidance/default.aspx, https://www.iqvia.com/about-us, https://www.sec.gov/Archives/edgar/data/1478242/000162828026012899/ars_2025.pdf |
| 营收 | 2025年$163.1亿 | https://ir.iqvia.com/press-releases/press-release-details/2026/IQVIA-Reports-Fourth-Quarter-and-Full-Year-2025-Results-Issues-Full-Year-2026-Guidance/default.aspx |
| 认证 | GCLP、GLP、AAALAC、CCAC、OLAW及BBL（视基地而定） | https://labs.iqvia.com/vaccines-site-laval, https://labs.iqvia.com/vaccines-site-marburg |
| 生产基地 | 全球多处实验室，包括北卡罗来纳州Durham、印第安纳州印第安纳波利斯、纽约州Ithaca、加利福尼亚州Valencia、佐治亚州Marietta、魁北克Laval、德国马尔堡及中国北京 [中等置信度] | https://labs.iqvia.com/locations, https://labs.iqvia.com/vaccines-site-laval, https://labs.iqvia.com/vaccines-site-marburg, https://labs.iqvia.com/visitor-guide/beijing |

独立来源: sec.gov, umbrex.com

## 技术

- [医学事务平台（CME、MSL）](https://cn.bioecon.ru/technology/medical-affairs-platforms/)
- [指定患者计划与同情用药](https://cn.bioecon.ru/technology/named-patient-compassionate-use/)